AMPK activity is diminished in tissues of IL-6 knockout mice: The effect of exercise

Biochemical and Biophysical Research Communications

Volumn 320, Issue 2, 2004, Pages 449-454

  Kelly, Meghan ^a   Keller, Charlotte ^b   Avilucea, Paco R ^a   Keller, Pernille ^b   Luo, Zhijun ^a   Xiang, Xiaoquin ^a   Giralt, Mercé ^c   Hidalgo, Juan ^c   Saha, Asish K ^a   Pedersen, Bente K ^b   Ruderman, Neil B ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Rigshospitalet   (Denmark)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

AMPK; Diabetes; Exercise; IL 6

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENOSINE PHOSPHATE; INTERLEUKIN 6; PROTEIN KINASE;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXTENSOR DIGITORUM LONGUS MUSCLE; FEMALE; IN VIVO STUDY; INCUBATION TIME; INTERMETHOD COMPARISON; KNOCKOUT MOUSE; MALE; MEASUREMENT; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; REGULATORY MECHANISM; SKELETAL MUSCLE; TISSUE DISTRIBUTION;

ADIPOCYTES; ANIMALS; FEMALE; INTERLEUKIN-6; LIVER; MICE; MICE, KNOCKOUT; MULTIENZYME COMPLEXES; MUSCLE, SKELETAL; PHYSICAL CONDITIONING, ANIMAL; PROTEIN-SERINE-THREONINE KINASES; RATS;

EID: 2942748289     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.05.188     Document Type: Article

References (37)

1. Tomas E., Tsao T.S., Saha A.K., Murrey H.E., Zhang C.C., Itani S.I., Lodish H.F., Ruderman N.B. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl. Acad. Sci. USA. 99:2002;16309-16313
2. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B.B., Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8:2002;1288-1295
3. Minokoshi Y., Kim Y.B., Peroni O.D., Fryer L.G., Muller C., Carling D., Kahn B.B. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature. 415:2002;339-343
4. Ruderman N.B., Park H., Kaushik V.K., Dean D., Constant S., Prentki M., Saha A.K. AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise. Acta Physiol. Scand. 178:2003;435-442
5. Carling D. The AMP-activated protein kinase cascade - a unifying system for energy control. Trends Biochem. Sci. 29:2004;18-24
6. Kemp B.E., Stapleton D., Campbell D.J., Chen Z.P., Murthy S., Walter M., Gupta A., Adams J.J., Katsis F., van Denderen B., Jennings I.G., Iseli T., Michell B.J., Witters L.A. AMP-activated protein kinase, super metabolic regulator. Biochem. Soc. Trans. 31:2003;162-168
7. Hardie D.G., Scott J.W., Pan D.A., Hudson E.R. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 546:2003;113-120
8. ′-AMP-activated kinase in skeletal muscle. J. Biol. Chem. 272:1997;13255-13261
9. Winder W.W., Hardie D.G. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am. J. Physiol. 277:1999;E1-E10
10. Park H., Kaushik V.K., Constant S., Prentki M., Przybytkowski E., Ruderman N.B., Saha A.K. Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J. Biol. Chem. 277:2002;32571-32577
11. Pedersen B.K., Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol. Rev. 80:2000;1055-1081
12. Kern P.A., Ranganathan S., Li C., Wood L., Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 280:2001;E745-E751
13. Keller P., Keller C., Carey A.L., Jauffred S., Fischer C.P., Steensberg A., Pedersen B.K. Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6. Biochem. Biophys. Res. Commun. 310:2003;550-554
14. Penkowa M., Keller C., Keller P., Jauffred S., Pedersen B.K. Immunohistochemical detection of interleukin-6 in human skeletal muscle fibers following exercise. FASEB J. 2003
15. Febbraio M.A., Pedersen B.K. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J. 16:2002;1335-1347
16. Pedersen B.K., Steensberg A., Schjerling P. Muscle-derived interleukin-6: possible biological effects. J. Physiol. 536:2001;329-337
17. Keller C., Steensberg A., Pilegaard H., Osada T., Saltin B., Pedersen B.K., Neufer P.D. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J. 15:2001;2748-2750
18. Wallenius V., Wallenius K., Ahren B., Rudling M., Carlsten H., Dickson S.L., Ohlsson C., Jansson J.O. Interleukin-6-deficient mice develop mature-onset obesity. Nat. Med. 8:2002;75-79
19. Saha A.K., Kurowski T.G., Ruderman N.B. A malonyl-CoA fuel-sensing mechanism in muscle: effects of insulin, glucose, and denervation. Am. J. Physiol. 269:1995;E283-289
20. Moule S.K., Denton R.M. The activation of p38 MAPK by the beta-adrenergic agonist isoproterenol in rat epididymal fat cells. FEBS Lett. 439:1998;287-290
21. Baumann H., Morella K.K., White D.W., Dembski M., Bailon P.S., Kim H., Lai C.F., Tartaglia L.A. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc. Natl. Acad. Sci. USA. 93:1996;8374-8378
22. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374:2003;1-20
23. Faldt J., Wernstedt I., Fitzgerald S.M., Wallenius K., Bergstrom G., Jansson J.O. Reduced exercise endurance in interleukin-6 deficient mice. Endocrinology. 2004
24. Mu J., Barton E.R., Birnbaum M.J. Selective suppression of AMP-activated protein kinase in skeletal muscle: update on 'lazy mice'. Biochem. Soc. Trans. 31:2003;236-241
25. Ruderman N.B., Saha A.K., Kraegen E.W. Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology. 144:2003;5166-5171
26. Ido Y., Carling D., Ruderman N. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. Diabetes. 51:2002;159-167
27. J. Cacicedo, N. Yagihashi, J.F. Keaney, N.B. Ruderman, Y. Ido, Activation of AMPK inhibits fatty acid-induced increases in apoptosis, oxidant stress, and NF-κB transactivation in cultured human umbilical vein endothelium, submitted
28. Kobayashi H., Ouchi N., Kihara S., Walsh K., Kumada M., Abe Y., Funahashi T., Matsuzawa Y. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res. 94:2004;e27-31
29. Kelley D.E., He J., Menshikova E.V., Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 51:2002;2944-2950
30. Petersen K.F., Dufour S., Befroy D., Garcia R., Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350:2004;664-671
31. Petersen K.F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D.L., DiPietro L., Cline G.W., Shulman G.I. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 300:2003;1140-1142
32. Park S.H., Gammon S.R., Knippers J.D., Paulsen S.R., Rubink D.S., Winder W.W. Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle. J. Appl. Physiol. 92:2002;2475-2482
33. Pedersen B.K., Steensberg A., Keller P., Keller C., Fischer C., Hiscock N., Van Hall G., Plomgaard P., Febbraio M.A. Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects. Pflugers Arch. 446:2003;9-16
34. Haffner S.M. Insulin resistance, inflammation, and the prediabetic state. Am. J. Cardiol. 92:2003;18J-26J
35. Ridker P.M. Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view. Blood Coagul. Fibrinolysis. 10(Suppl. 1):1999;S9-S12
36. Starkie R., Ostrowski S.R., Jauffred S., Febbraio M., Pedersen B.K. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J. 17:2003;884-886
37. Selle T., Tietge U., Winkler K., Hilfinker A., Schieffer B. Interleukin-6 deficiency enhances atherosclerotic plaque formation and plaque destabilization in experimental atherosclerosis. Circulation. 108(Suppl. IV):2003;66